Home>Topics>Companies>St. Jude Medical

St. Jude Medical STJ

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Cramer's Lightning Round - I Still Believe In Rite Aid (7/25/14)

      Headlines

      Sun, 27 Jul 2014

      to $9. It is churning, and that is okay." St . Jude Medical (NYSE: STJ ): " STJ is my preferred pick in that category ..... MDT ), Covidien (NYSE: COV ): Cramer prefers St . Jude Medical to these stocks. Weatherford (NYSE: WFT

    2. Boston Scientific Exceeds Our Expectations in the Second Quarter

      Commentary

      Thu, 24 Jul 2014

      ICD, Boston racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St . Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston

    3. European regulatory clearance for St . Jude catheter

      Headlines

      Tue, 22 Jul 2014

      St . Jude Medical 's (NYSE: STJ ) Flexibility Ablation Catheter achieves CE Mark clearance in Europe. The product has a flexible tip that reduces complications

    4. UPDATE 2- St . Jude not keen to join inversion deal craze

      Headlines

      Wed, 16 Jul 2014

      July 16 (Reuters) - Heart device maker St . Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not

    5. St . Jude Medical's ( STJ ) CEO Dan Starks on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical Inc. (NYSE: STJ ) Q2 2014 Results Earnings Conference ..... Presentation Operator Welcome to the St . Jude Medical Second Quarter 2014 Earnings Conference ..... and Chief Executive Officer of St . Jude Medical . Before we begin, let me remind

    6. St Jude Medical's quarterly profit doubles as expenses fall

      Headlines

      Wed, 16 Jul 2014

      July 16 (Reuters) - Heart device maker St . Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.

    7. More on St . Jude Q2 earnings. 2014 guidance raised.

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical (NYSE: STJ ) Q2 results: Total Revenues: $1,448M (+3.2%); ICD: $462M (+1.8%); Pacemakers: $271M (+2.7%); AF

    8. St . Jude Medical beats by $0.02, beats on revenue

      Headlines

      Wed, 16 Jul 2014

      St . Jude Medical (NYSE: STJ ): Q2 EPS of $1.02 beats by $0.02 . Revenue of $1.45B (+3.6% Y/Y) beats by $10M . Press Release Post your comment!

    9. St . Jude Delivers Solid 2Q Results

      Commentary

      Wed, 16 Jul 2014

      St . Jude Medical posted solid second-quarter performance ..... estimate in place. We were heartened to see St . Jude 's sales of implantable cardioverter defibrillators ..... recently declined in the low single digits. St . Jude 's recent acquisition of Cardiomems

    10. St . Jude buys NeuroTherm

      Headlines

      Mon, 14 Jul 2014

      St . Jude Medical ( STJ -0.8% ) enters into a definitive agreement to acquire privately ..... conclude the transaction in late Q3. NeuroTherm will add $10M - 15M to STJ 's top-line sales in 2014. NeuroTherm's technology utilizes radiofrequency

    « Prev12345Next »
    Content Partners